Ann: Afamelanotide well tolerated by first stroke patients, page-10

Don't think anyone claimed any great statistical significance at this point in time. Early days of the trial, no adverse reactions to afamelanotide in vulnerable patients. Sounds OK, especially since safety is the primary endpoint. Certainly too early to count chickens, but certainly not bad news either. As far as it goes, pleasing to see.

Decades of research and clinical trials into melanocortins, a novel field of pharmaceuticals, has now seen 3 products approved for different indications.

The side effects of afamelanotide are so bad that 95% of patients seek repeat treatment. Wow, must be awful to be on it!

Patients who do not tan significantly also report significant benefits from being on the medication. Kinda doesn't make sense if tanning is the only effect the medication stimulates.

Kodak invented the digital camera. They didn't realise it's significance. A few years later they were bankrupt. Being big doesn't always mean being right.

Originally posted by PigsMightFly